A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies

Clinical trial NCT07347171 · RECRUITING

Trial details

NCT number: NCT07347171
Sponsor: Cullgen (Shanghai),Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia AML MDS AML (Acute Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)

Start date: 2025-04-17
Primary completion: 2027-12-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.